Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease

被引：0
|
作者：
Milosevic, V. [1 ]
Petrovic, M. [1 ]
Mihaljevic, B. [1 ]
Jankovic, S. [1 ]
Nedeljkov, R. Jancic [1 ]
Boskovic, D. [1 ]
机构：
[1] Inst Hematol, Belgrade, Serbia
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1239
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [41] COMPLETE RESPONSE TO IGEV (IFOSFAMIDE, GEMCITABINE AND VINORELBINE) AND OUTCOME IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA PATIENTS
    Anastasia, A.
    Mazza, R.
    Giordano, L.
    Balzarotti, M.
    Magagnoli, M.
    Castagna, L.
    Spina, M.
    Tirelli, U.
    Santoro, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 37 - 37
  • [42] Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine
    Sezer, O
    Eucker, J
    Jakob, C
    Kaufmann, O
    Schmid, P
    Possinger, K
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 101 - 104
  • [43] Achievement of Complete Remission in Refractory Hodgkin's Disease with Prolonged Infusion of Gemcitabine
    Orhan Sezer
    Jan Eucker
    Christian Jakob
    Olaf Kaufmann
    Peter Schmid
    Kurt Possinger
    Investigational New Drugs, 2001, 19 : 101 - 104
  • [44] Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel
    Mora, Jaume
    Ofelia Cruz, Cheeu
    Parareda, Andreu
    de Torres, Carmen
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (10) : 723 - 729
  • [45] Treatment of relapsed/refractory pediatric sarcomas with gemcitabine and docetaxel
    Cruz, O.
    Mora, J.
    Parareda, A.
    de Torres, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [46] High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
    Ryszard Swoboda
    Sebastian Giebel
    Wanda Knopińska-Posłuszny
    Ewa Chmielowska
    Joanna Drozd-Sokołowska
    Ewa Paszkiewicz-Kozik
    Waldemar Kulikowski
    Michał Taszner
    Włodzimierz Mendrek
    Jacek Najda
    Tomasz Czerw
    Magdalena Olszewska-Szopa
    Anna Czyż
    Agnieszka Giza
    Wojciech Spychałowicz
    Edyta Subocz
    Paweł Szwedyk
    Aleksandra Krzywon
    Agata Wilk
    Jan Maciej Zaucha
    Annals of Hematology, 2021, 100 : 1755 - 1767
  • [47] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    Bone Marrow Transplantation, 1997, 20 : 369 - 374
  • [48] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [49] Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease
    Bonfante, V
    Viviani, S
    Santoro, A
    Devizzi, L
    Di Russo, A
    Zanini, M
    Soncini, F
    Parra, HS
    Valagussa, P
    Bonadonna, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (02) : 533 - 535
  • [50] Role of allogeneic stem cell transplantation in relapsed or refractory Hodgkin's disease
    Sureda, A
    Schmitz, N
    ANNALS OF ONCOLOGY, 2002, 13 : 128 - 132
12345